Early Warning of Intradialytic Hypotension in Hemodialysis Patients

Hypotension of Hemodialysis Clinical Trial

Official title:
Noninvasive Hemodynamic Parameters Measurements as a Tool for Early Warning of Intradialytic Hypotension in Hemodialysis Patients

Status Completed

Clinical Trial Summary

In this study, the investigators will monitor patients undergoing hemodialysis treatment with a non-invasive wearable PPG-based device. Measurements will include blood pressure, heart rate, oxygen saturation, stroke volume, cardiac output, cardiac index and systemic vascular resistance, among others. The aim is to diagnose intradialytic hypotension more rapidly than with current noninvasive methods and prevent related poor outcomes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04680039
Study type	Observational
Source	Biobeat Technologies Ltd.
Contact
Status	Completed
Phase
Start date	January 15, 2021
Completion date	March 15, 2022

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05297786` - Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease	Phase 2
	Active, not recruiting	`NCT02182089` - Measuring Cardiovascular Stress in Patients on Hemodialysis Study II